Predicting response to anti-EGFR antibody, cetuximab, therapy by monitoring receptor internalization and degradation
出版年份 2023 全文链接
标题
Predicting response to anti-EGFR antibody, cetuximab, therapy by monitoring receptor internalization and degradation
作者
关键词
-
出版物
BIOMATERIALS
Volume -, Issue -, Pages 122382
出版商
Elsevier BV
发表日期
2023-11-03
DOI
10.1016/j.biomaterials.2023.122382
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer
- (2023) Jia‐Yi Lin et al. Small
- Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
- (2023) Kun Wang et al. Advanced Science
- Antibody‐Incorporated Nanomedicines for Cancer Therapy
- (2022) Shun‐Yu Wu et al. ADVANCED MATERIALS
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Enzyme‐Engineered Conjugated Polymer Nanoplatform for Activatable Companion Diagnostics and Multistage Augmented Synergistic Therapy
- (2022) Jiayingzi Wu et al. ADVANCED MATERIALS
- Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers
- (2022) Jinfeng Yu et al. Frontiers in Molecular Biosciences
- Semiconducting Polymer Nanoparticles with Surface‐Mimicking Protein Secondary Structure as Lysosome‐Targeting Chimaeras for Self‐Synergistic Cancer Immunotherapy
- (2022) Ji Qi et al. ADVANCED MATERIALS
- LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
- (2021) Green Ahn et al. Nature Chemical Biology
- ZNRF1 Mediates Epidermal Growth Factor Receptor Ubiquitination to Control Receptor Lysosomal Trafficking and Degradation
- (2021) Chia-Hsing Shen et al. Frontiers in Cell and Developmental Biology
- Antibody‐Drug‐Conjugate Therapy for Hematological Cancers: Matching Cell Biology with Clinical Benefit
- (2021) Michael A. Firer et al. ADVANCED FUNCTIONAL MATERIALS
- Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation
- (2020) Sylwia Jones et al. Scientific Reports
- Lysosome-targeting chimaeras for degradation of extracellular proteins
- (2020) Steven M. Banik et al. NATURE
- Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug
- (2020) Han Young Kim et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab
- (2018) Huanrong Ma et al. INTERNATIONAL JOURNAL OF CANCER
- EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer
- (2017) Yasuyuki Okada et al. MOLECULAR CANCER RESEARCH
- Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging
- (2016) Man Kyu Shim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cloning and Expression of a Novel Target Fusion Protein and its Application in Anti-Tumor Therapy
- (2015) Rui Sun et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- CCR 20th Anniversary Commentary: A Chimeric Antibody, C225, Inhibits EGFR Activation and Tumor Growth
- (2015) J. Mendelsohn et al. CLINICAL CANCER RESEARCH
- In vivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobe
- (2013) Ju Hee Ryu et al. BIOMATERIALS
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
- (2010) M. W. Pedersen et al. CANCER RESEARCH
- The effect of bafilomycin A1 and protease inhibitors on the degradation and recycling of a Class 5-mutant LDLR
- (2009) K. Tveten et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- An A13 Repeat within the 3'-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression
- (2009) Z. Yuan et al. CANCER RESEARCH
- Cetuximab/C225-Induced Intracellular Trafficking of Epidermal Growth Factor Receptor
- (2009) H.-J. Liao et al. CANCER RESEARCH
- Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
- (2009) C. Shah et al. CLINICAL CANCER RESEARCH
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now